John G. Bartlett, M.D., Johns Hopkins University School of Medicine, Baltimore, MD, has been honored with the prestigious Cubist-ICAAC Award from the American Society for Microbiology. Supported by Cubist Pharmaceuticals, the award rewards outstanding accomplishment in antimicrobial chemotherapy, development of new agents, investigation of antimicrobial action or resistance to antimicrobial agents, and/or the pharmacology, toxicology or clinical use of those agents.
Dr. Bartlett served as Chief of the Infectious Disease Division at the School for 26 years, stepping down in July of 2006. Thomas O'Brien, Academy Fellow from Harvard Medical School, says that Dr. Bartlett "has contributed more to our understanding of numerous kinds of infecting microbes and their interactions with antimicrobial agents than anyone else I can think of." "Dr. Bartlett's career is distinguished by the breadth of his contributions to ID; the depth of his knowledge across the field; and his enormous productivity. He is a true visionary, able to predict the importance of emerging problems and innovations before most people have taken notice," adds a supporter of the nomination, Joel E. Gallant of Johns Hopkins University School of Medicine.
Dr. Bartlett received his undergraduate degree at Dartmouth College, Hanover, NH, and his medical degree at Upstate Medical Center, Syracuse, NY. He trained in internal medicine at the Peter Bent Brigham Hospital, Boston, MA, and the University of Alabama, Birmingham, and he completed his fellowship training in infectious diseases at the University of California, Los Angeles (UCLA). Before accepting his current position at The Johns Hopkins University, Dr. Bartlett served as a faculty member at UCLA and Tufts University School of Medicine in Boston, MA, and was associate chief of staff for research at the Boston VA Hospital.
Dr. Bartlett has worked in several areas of research, all related to his specialty in infectious d
|Contact: Garth Hogan|
American Society for Microbiology